Organism name | Salix spp. |
---|---|
Genus | Salix |
Family | Salicaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Salix |
---|---|
Linked NCBI taxonomy ID | 40685 |
Linked level | genus |
Family in NCBI taxonomy | Salicaceae |
---|---|
ID | 3688 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00006698
![]() |
Myrtillin
/ Delphinidin 3-O-beta-D-glucopyranoside |
CHEMBL518846
|
No. 2 | No. 15 |
![]() |
|||
C00008204
![]() |
Floribundoside
|
CHEMBL2152489
CHEMBL2152490 |
No. 12 | No. 14 |
![]() |
|||
C00009070
![]() |
Procyanidin B6
/ Catechin-(4alpha->6)-catechin |
CHEMBL506487
CHEMBL502984 CHEMBL451115 |
No. 16 | No. 19 |
![]() |
|||
C00009073
![]() |
Procyanidin B8
/ Catechin-(4alpha->6)-epicatechin |
CHEMBL506487
CHEMBL502984 CHEMBL451115 |
No. 16 | No. 19 |
![]() |
|||
C00008919
![]() |
Catechin-(2'->2')-taxifolin
|
No. 16 | No. 19 |
![]() |
||||
C00009089
![]() |
Arecatannin B1
|
CHEMBL592329
|
2 / 3 / 4 | No. 29 | No. 19 |
![]() |
||
C00009088
![]() |
Catechin-(4alpha->8)-catechin-(4alpha->6)-catechin
|
CHEMBL592329
|
2 / 3 / 4 | No. 29 | No. 19 |
![]() |
||
C00009085
![]() |
Catechin-(4alpha->6)-epicatechin-(4beta->8)-epicatechin
|
CHEMBL592228
|
2 / 3 / 4 | No. 29 | No. 19 |
![]() |
||
C00009086
![]() |
Epicatechin-(4beta->6)-epicatechin-(4beta->8)-catechin
|
CHEMBL592228
|
2 / 3 / 4 | No. 29 | No. 19 |
![]() |
||
C00009094
![]() |
Catechin-(4alpha->8)-epicatechin-(4beta->8)-epicatechin
|
CHEMBL290632
|
13 / 5 / 6 | No. 29 | No. 19 |
![]() |
||
C00001015
![]() |
Amentoflavone
|
CHEMBL63354
|
C011164
|
50 / 39 / 29 | 5 / 0 | No. 34 | No. 18 |
![]() |
C00002707
![]() |
Picein
/ 4-Hydroxyacetophenone 4-glucoside |
CHEMBL1512620
|
C050880
|
3 / 0 / 0 | No. 45 | No. 72 |
![]() |
|
C00002672
![]() |
Salicin
/ Saligenin beta-D-glucopyranoside |
CHEMBL334657
CHEMBL462997 CHEMBL1595746 |
C005696
|
5 / 1 / 4 | No. 45 | No. 72 |
![]() |
|
C00002719
![]() |
N-Caffeoylputrescine
|
No. 5072 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P08253 | 72 kDa type IV collagenase | M10A | C00001015 C00009085 C00009086 C00009088 C00009089 C00009094 | 1 / 3 |
P14780 | Matrix metalloproteinase-9 | M10A | C00009085 C00009086 C00009088 C00009089 C00009094 | 2 / 2 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00001015 C00002672 | 0 / 0 |
Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | C00001015 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00001015 | 3 / 1 |
O15496 | Group 10 secretory phospholipase A2 | Enzyme | C00001015 | 0 / 0 |
P49763 | Placenta growth factor | Unclassified protein | C00001015 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00001015 | 0 / 0 |
P14555 | Phospholipase A2, membrane associated | Enzyme | C00001015 | 0 / 0 |
P11216 | Glycogen phosphorylase, brain form | Enzyme | C00002672 | 0 / 0 |
P43235 | Cathepsin K | C1A | C00001015 | 1 / 2 |
P47712 | Cytosolic phospholipase A2 | Enzyme | C00001015 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00001015 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001015 | 2 / 2 |
P39748 | Flap endonuclease 1 | Enzyme | C00001015 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00001015 | 2 / 0 |
O75496 | Geminin | Unclassified protein | C00002707 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00001015 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00001015 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00001015 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001015 | 7 / 3 |
Q9Y253 | DNA polymerase eta | Enzyme | C00001015 | 1 / 1 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002707 | 0 / 0 |
P15692 | Vascular endothelial growth factor A | Secreted protein | C00001015 | 1 / 2 |
P56817 | Beta-secretase 1 | A1A | C00001015 | 0 / 0 |
Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | C00001015 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00001015 | 2 / 2 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001015 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00001015 | 0 / 0 |
P19174 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | Enzyme | C00001015 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002672 | 0 / 3 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001015 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002672 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00001015 | 4 / 3 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001015 | 0 / 0 |
O00167 | Eyes absent homolog 2 | Enzyme | C00002707 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002672 | 1 / 1 |
P55072 | Transitional endoplasmic reticulum ATPase | Unclassified protein | C00001015 | 2 / 1 |
O00255 | Menin | Unclassified protein | C00001015 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001015 | 1 / 2 |
Q05513 | Protein kinase C zeta type | Iota | C00009094 | 0 / 0 |
Q04759 | Protein kinase C theta type | Delta | C00009094 | 0 / 1 |
Q02156 | Protein kinase C epsilon type | Eta | C00009094 | 0 / 0 |
O94806 | Serine/threonine-protein kinase D3 | Pkd | C00009094 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00009094 | 0 / 0 |
Q05655 | Protein kinase C delta type | Delta | C00009094 | 0 / 0 |
P05129 | Protein kinase C gamma type | Alpha | C00009094 | 1 / 1 |
P05771 | Protein kinase C beta type | Alpha | C00009094 | 0 / 0 |
P24723 | Protein kinase C eta type | Eta | C00009094 | 1 / 0 |
P41743 | Protein kinase C iota type | Iota | C00009094 | 0 / 0 |
Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00009094 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001015 | 0 / 0 |
P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | C00001015 | 1 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00001015 | 1 / 1 |
P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | C00001015 | 0 / 0 |
O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | C00001015 | 1 / 1 |
P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | C00001015 | 0 / 0 |
Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | C00001015 | 0 / 0 |
P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | C00001015 | 0 / 0 |
Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | C00001015 | 0 / 0 |
P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | C00001015 | 0 / 0 |
O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | C00001015 | 0 / 0 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00001015 | 0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00001015 | 4 / 2 |
P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | C00001015 | 0 / 0 |
Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | C00001015 | 0 / 0 |
P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | C00001015 | 1 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001015 | 0 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00001015 | 2 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00001015
|
1638 | DCT, TRP-2, TYRP2 | dopachrome tautomerase (EC:5.3.3.12) |
C00001015
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00001015
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00001015
|
7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00001015
|
OMIM | preferred title | UniProt |
---|---|---|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#103780 | Alcohol dependence |
P47869
|
#613954 | Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia; als14 |
P55072
|
#114500 | Colorectal cancer; crc |
P84022
Q14191 |
#119900 | Digital clubbing, isolated congenital |
P15428
|
#607208 | Dravet syndrome |
P18507
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
#613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#167320 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 1; ibmpfd1 |
P55072
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#603933 | Microvascular complications of diabetes, susceptibility to, 1; mvcd1 |
P15692
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#265800 | Pycnodysostosis |
P43235
|
#605361 | Spinocerebellar ataxia 14; sca14 |
P05129
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601367 | Stroke, ischemic |
P24723
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277700 | Werner syndrome; wrn |
Q14191
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
H00063 | Spinocerebellar ataxia (SCA) |
P05129
(related)
Q9NUW8 (related) |
H00025 | Penile cancer |
P08253
(related)
P14780 (related) P35354 (related) |
H00028 | Choriocarcinoma |
P08253
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
P55072 (related) |
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00018 | Gastric cancer |
P15692
(related)
|
H00021 | Renal cell carcinoma |
P15692
(marker)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00017 | Esophageal cancer |
P35354
(related)
|
H00046 | Cholangiocarcinoma |
P35354
(related)
|
H00273 | Pycnodysostosis |
P43235
(related)
|
H00425 | Lysosomal cysteine protease deficiencies |
P43235
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00408 | Type I diabetes mellitus |
Q04759
(related)
|
H00296 | Defects in RecQ helicases |
Q14191
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|